Amedisys (NASDAQ:AMED – Get Free Report) announced its earnings results on Wednesday. The health services provider reported $1.00 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.19 by ($0.19), Briefing.com reports. Amedisys had a net margin of 4.02% and a return on equity of 12.39%. The business had revenue of $587.67 million for the quarter, compared to analysts’ expectations of $586.75 million. During the same quarter last year, the firm earned $0.98 EPS. The firm’s quarterly revenue was up 5.7% on a year-over-year basis.
Amedisys Trading Down 0.9 %
Shares of Amedisys stock traded down $0.85 on Thursday, hitting $96.86. 344,405 shares of the company traded hands, compared to its average volume of 337,286. The company has a market cap of $3.17 billion, a PE ratio of 34.90, a PEG ratio of 1.87 and a beta of 0.78. Amedisys has a 52 week low of $89.55 and a 52 week high of $98.95. The company has a current ratio of 1.16, a quick ratio of 1.16 and a debt-to-equity ratio of 0.30. The stock’s 50 day moving average price is $96.75 and its 200-day moving average price is $95.77.
Analyst Upgrades and Downgrades
Several brokerages have issued reports on AMED. Deutsche Bank Aktiengesellschaft lowered Amedisys from a “buy” rating to a “hold” rating and set a $101.00 target price for the company. in a research report on Monday, July 29th. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $101.00 price target on shares of Amedisys in a research note on Thursday, July 25th. Four analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Amedisys has an average rating of “Hold” and an average price target of $100.67.
Amedisys Company Profile
Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.
See Also
- Five stocks we like better than Amedisys
- Bank Stocks – Best Bank Stocks to Invest In
- Gilead’s Stock Surge: What’s Fueling the Momentum?
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Breakout Alert: Qualcomm Just Hit The Rally Button
- What is the Euro STOXX 50 Index?
- Mercado Libre Shares Go on Sale: Is Now the Time to Buy?
Receive News & Ratings for Amedisys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amedisys and related companies with MarketBeat.com's FREE daily email newsletter.